Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma?
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | Brain and Spine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772529423004058 |
| _version_ | 1797671929731088384 |
|---|---|
| author | Alice Dauth Harald Krenzlin Felipa Lange Florian Ringel Naureen Keric |
| author_facet | Alice Dauth Harald Krenzlin Felipa Lange Florian Ringel Naureen Keric |
| author_sort | Alice Dauth |
| collection | DOAJ |
| first_indexed | 2024-03-11T21:22:41Z |
| format | Article |
| id | doaj.art-1f62658c9c474f908d88b6f39eaf05da |
| institution | Directory Open Access Journal |
| issn | 2772-5294 |
| language | English |
| last_indexed | 2024-03-11T21:22:41Z |
| publishDate | 2023-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Brain and Spine |
| spelling | doaj.art-1f62658c9c474f908d88b6f39eaf05da2023-09-28T05:28:21ZengElsevierBrain and Spine2772-52942023-01-013102117Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma?Alice Dauth0Harald Krenzlin1Felipa Lange2Florian Ringel3Naureen Keric4University Medical Center of Johannes Gutenberg-University , Mainz, GermanyUniversity Medical Center of Johannes Gutenberg-University , Mainz, GermanyUniversity Medical Center of Johannes Gutenberg-University , Mainz, GermanyUniversity Medical Center of Johannes Gutenberg-University , Mainz, GermanyUniversity Medical Center of Johannes Gutenberg-University , Mainz, Germanyhttp://www.sciencedirect.com/science/article/pii/S2772529423004058 |
| spellingShingle | Alice Dauth Harald Krenzlin Felipa Lange Florian Ringel Naureen Keric Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma? Brain and Spine |
| title | Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma? |
| title_full | Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma? |
| title_fullStr | Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma? |
| title_full_unstemmed | Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma? |
| title_short | Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma? |
| title_sort | regorafenib a feasible option as third line therapy of recurrent glioblastoma |
| url | http://www.sciencedirect.com/science/article/pii/S2772529423004058 |
| work_keys_str_mv | AT alicedauth regorafenibafeasibleoptionasthirdlinetherapyofrecurrentglioblastoma AT haraldkrenzlin regorafenibafeasibleoptionasthirdlinetherapyofrecurrentglioblastoma AT felipalange regorafenibafeasibleoptionasthirdlinetherapyofrecurrentglioblastoma AT florianringel regorafenibafeasibleoptionasthirdlinetherapyofrecurrentglioblastoma AT naureenkeric regorafenibafeasibleoptionasthirdlinetherapyofrecurrentglioblastoma |